Skip to content

Increasing PrEP Among African Americans in Louisville KY

Increasing Pre-exposure Prophylaxis Among High-Risk African Americans in Louisville KY

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03559595
Enrollment
205
Registered
2018-06-18
Start date
2018-06-04
Completion date
2020-12-31
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS PREVENTION

Brief summary

This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.

Interventions

BEHAVIORALProject Prevent

The Project Prevent intervention entails 1) a media campaign to raise PrEP awareness, 2) geographically targeted education initiatives with medical personnel to increase access to consumers, and 3) programming with AIDS service organizations to improve service delivery around PrEP.

Sponsors

University of Louisville
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Between ages 18-29 years old * Self-identifies as African American or Black * Resident of Louisville, KY * Member of a priority group for PrEP HIV prevention (Men who have sex with men, people who inject drugs, trans women, high risk heterosexuals, people in serodiscordant relationships). * Not diagnosed with HIV

Exclusion criteria

* Older than 29 and younger than 18 years old * Does not identify as African American or Black * Does not reside in Louisville, KY * Not a member of a priority group * Diagnosed with HIV

Design outcomes

Primary

MeasureTime frameDescription
PrEP uptake12 monthsReported use of PrEP

Secondary

MeasureTime frameDescription
PrEP intentions12 monthsIntention to use PrEP
PrEP prescription12 monthsPrescription of PrEP to eligible individuals by medical personnel

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026